104 related articles for article (PubMed ID: 20689430)
1. Imaging and response criteria in gliomas.
Gerstner ER; Batchelor TT
Curr Opin Oncol; 2010 Nov; 22(6):598-603. PubMed ID: 20689430
[TBL] [Abstract][Full Text] [Related]
2. Mathematical modeling of glioma on MRI.
Mandonnet E
Rev Neurol (Paris); 2011 Oct; 167(10):715-20. PubMed ID: 21890155
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas.
Hori M; Mori H; Aoki S; Abe O; Masumoto T; Kunimatsu S; Ohtomo K; Kabasawa H; Shiraga N; Araki T
Magn Reson Imaging; 2010 May; 28(4):594-8. PubMed ID: 20233645
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and invasion in glioma.
Onishi M; Ichikawa T; Kurozumi K; Date I
Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
[TBL] [Abstract][Full Text] [Related]
7. Vessel size imaging using dual contrast agent injections.
Hsu YY; Yang WS; Lim KE; Liu HL
J Magn Reson Imaging; 2009 Nov; 30(5):1078-84. PubMed ID: 19856441
[TBL] [Abstract][Full Text] [Related]
8. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
9. Changing boundaries in the treatment of malignant gliomas.
Brandes AA; Basso U; Pasetto LM
Expert Rev Anticancer Ther; 2001 Oct; 1(3):357-70. PubMed ID: 12113103
[TBL] [Abstract][Full Text] [Related]
10. Low-grade gliomas in adults.
Sanai N; Chang S; Berger MS
J Neurosurg; 2011 Nov; 115(5):948-65. PubMed ID: 22043865
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
[TBL] [Abstract][Full Text] [Related]
12. Targeting the tumor vasculature to improve the efficacy of oncolytic virus therapy.
Rhim JH; Tosato G
J Natl Cancer Inst; 2007 Dec; 99(23):1739-41. PubMed ID: 18042930
[No Abstract] [Full Text] [Related]
13. Local endostatin treatment of gliomas administered by microencapsulated producer cells.
Read TA; Sorensen DR; Mahesparan R; Enger PO; Timpl R; Olsen BR; Hjelstuen MH; Haraldseth O; Bjerkvig R
Nat Biotechnol; 2001 Jan; 19(1):29-34. PubMed ID: 11135548
[TBL] [Abstract][Full Text] [Related]
14. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
15. A low-field intraoperative MRI system for glioma surgery: is it worthwhile?
Oh DS; Black PM
Neurosurg Clin N Am; 2005 Jan; 16(1):135-41. PubMed ID: 15561533
[TBL] [Abstract][Full Text] [Related]
16. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management].
Metellus P; Dutertre G; Mekkaoui C; Nanni I; Fuentes S; Ait-Ameur A; Chinot O; Dufour H; Figarella-Branger D; Cordoliani YS; Grisoli F
Neurochirurgie; 2008 Aug; 54(4):503-11. PubMed ID: 18573509
[TBL] [Abstract][Full Text] [Related]
17. Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering.
Emblem KE; Nedregaard B; Hald JK; Nome T; Due-Tonnessen P; Bjornerud A
J Magn Reson Imaging; 2009 Jul; 30(1):1-10. PubMed ID: 19557840
[TBL] [Abstract][Full Text] [Related]
18. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
Leonardi MA; Lumenta CB
Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
[TBL] [Abstract][Full Text] [Related]
20. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.
Wen PY; Macdonald DR; Reardon DA; Cloughesy TF; Sorensen AG; Galanis E; Degroot J; Wick W; Gilbert MR; Lassman AB; Tsien C; Mikkelsen T; Wong ET; Chamberlain MC; Stupp R; Lamborn KR; Vogelbaum MA; van den Bent MJ; Chang SM
J Clin Oncol; 2010 Apr; 28(11):1963-72. PubMed ID: 20231676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
